Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA to Convene Pharmacy Compounding Advisory Committee in July Are Peptides coming off of the FDA Category 2 list? A legal breakdown. FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Is BPC 157 Banned? Oral vs. Injectable Forms Explained Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.